Price Targets For Calliditas

Stockholm Stock Exchange

Calliditas

0.00% (0.00)

Pareto SecuritiesSEBCitigroupKepler CheuvreuxCarnegieGuggenheim SecuritiesBryan GarnierCiti Investment ResearchKempenSEB Equities

Latest Target

0.00%

208.00 SEK

Pareto Securities

Jun -24

208.00 SEK

All Price Targets For Calliditas

Pareto Securities

Jun -24

Target: 208.00 SEKPrice: 208.00 SEK

0.00%

SEB

Jun -24

Target: 208.00 SEKPrice: 208.00 SEK

0.00%

Citigroup

May -24

Target: 413.32 SEKPrice: 208.00 SEK

+98.71%

Kepler Cheuvreux

Feb -24

Target: 125.00 SEKPrice: 208.00 SEK

-39.90%

Carnegie

Feb -24

Target: 171.00 SEKPrice: 208.00 SEK

-17.79%

Guggenheim Securities

Apr -23

Target: 231.05 SEKPrice: 208.00 SEK

+11.08%

Bryan Garnier

Sep -22

Target: 190.00 SEKPrice: 208.00 SEK

-8.65%

Citi Investment Research

Dec -21

Target: 384.00 SEKPrice: 208.00 SEK

+84.62%

Kempen

Dec -21

Target: 320.00 SEKPrice: 208.00 SEK

+53.85%

SEB Equities

Nov -21

Target: 75.00 SEKPrice: 208.00 SEK

-63.94%

About The Company

Calliditas vision is to leverage its interdisciplinary expertise in pharmaceutical product development to identify, develop and commercialize novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.
Calliditas